Purchase Order 75N95022P00670
Award Date
9/20/22
Potential Completion Date
12/20/22
Potential Value
$336K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Regenhu SA
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health awarded a firm-fixed-price purchase order to Regenhu SA, doing business as Regenhu LTD, for a BIOPRINTER valued at $198,010.00. The bioprinting equipment and platforms will support medical research programs involving disease models, neuronal circuits, neuromuscular junctions, pain, and addiction. This award was made on a sole-source basis without any set-aside designation. Regenhu SA has received multiple similar federal...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $476,450.33 firm-fixed-price purchase order to Regenhu SA, doing business as Regenhu LTD, for a 3D Discovery Instrument. Regenhu SA is a manufacturer of bioprinting equipment and platforms that support medical research. The purchase order was not set aside for any specific type of business. The 3D Discovery Instrument will be delivered to support research programs involving...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price contract to Regenhu SA, doing business as Regenhu LTD, for the delivery of volumetric cartridges in 2.5 ml and 5 ml sizes. The contract has a potential value of $10,285.27 and a completion date of July 23, 2024. Regenhu SA is a for-profit organization that manufactures bioprinting equipment and platforms to support medical research. This...
This is a $245,042.32 firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 to Regenhu SA, a manufacturer of bioprinting equipment and platforms that support medical research. The contract is for a 3D Discovery Printer, which is classified under North American Industry Classification System code 334516 for analytical laboratory instrument manufacturing and Federal Supply Class 6515 for medical and surgical instruments. The contract...
This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Cellink LLC, a foreign-owned for-profit biotech company based in Germany. The $85,489.00 contract is for the procurement of a BIONOVA X 3D bioprinter and associated software, bioink, warranty, and installation/training services. This requirement was a streamlined solicitation for commercial items with...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $230,620 purchase order to Cimquest Inc. to procure an XM200G 3D printer. As the prime contractor, Cimquest will deliver the requested 3D printing system to support research efforts. Performance will take place at Cimquest's New Jersey facility over approximately two months. No subcontractors or set aside designations were indicated. This award advances the NIH's mission to...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order contract to Advanced Solutions Life Sciences, LLC, a for-profit limited liability company, for the purchase of one BIOASSEMBLYBOT 200 Cell Dive Automation Workstation, a 3D bioprinting system, for $82,385. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Advanced Solutions Life Sciences is a leading...
The Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse awarded a firm fixed-price purchase order to Stratasys, Inc., a foreign-owned, for-profit manufacturer, to provide an FDM 3D printer for $160,154.55. The contract has a completion date of November 11, 2020. The printer will be used to support the engineering and fabrication needs of the Section on Instrumentation group. The contract is not set aside for small businesses. Stratasys, Inc....
Stratasys, Inc. was awarded a $15,600 purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute for 3D printer maintenance renewal services in 2023. The contract has a period of performance from September 15, 2023 through September 15, 2024 and utilizes a firm fixed price pricing structure. Stratasys will provide maintenance and support services for 3D printers located at the National Institutes of Health campus in...
This firm fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to 3D Systems, Inc. for a preventative maintenance and service agreement for a 3D Systems Project 6000 printer. The contract, valued at $79,654.52, will provide maintenance and support services to ensure the printer remains operational to support NIDA's rapid prototyping and manufacturing needs, particularly for MRI-compatible parts and...